Abstract:To identify new structure-function correlations in the ␥ domain of streptokinase, mutants were generated by error-prone random mutagenesis of the ␥ domain and its adjoining region in the  domain followed by functional screening specifically for substrate plasminogen activation. Single-site mutants derived from various multipoint mutation clusters identified the importance of discrete residues in the ␥ domain that are important for substrate processing. Among the various residues, aspartate at position 328 was… Show more
“…Numerous studies have been aimed at elucidating the function of each SK domain in hPg/hPm binding and activation. Various SK variants, including single and multiple domain constructs and point mutations [8][9][10][11][12][13][14][15][16][17][18][19], have been generated to attempt to clarify the functions of each of the SK domains in hPg binding and activation. Collectively, these studies generated a complex mixture of functional effects leading to a variety of different conclusions, but all of these studies agreed that there is some level of cooperation between the domains in hPg activation.…”
Cluster 1 streptokinases (SK1) from Streptococcus pyogenes (GAS) show substantially higher human plasminogen (hPg) activation activities and tighter hPg binding affinities than cluster 2b streptokinases (SK2b) in solution. The extent to which the different domains of SK are responsible for these differences is unknown. We exchanged each of the three known SK domains (α, β, and γ) between SK1 and SK2b and assessed the function of the resulting variants. Our results show that primary structural differences in the β-domains dictate these functional differences. This first report on the primary structure–functional relationship between naturally occurring SK1 and SK2b sheds new light on the mechanism of hPg activation by SK, a critical virulence determinant in this species of human pathogenic bacteria.
“…Numerous studies have been aimed at elucidating the function of each SK domain in hPg/hPm binding and activation. Various SK variants, including single and multiple domain constructs and point mutations [8][9][10][11][12][13][14][15][16][17][18][19], have been generated to attempt to clarify the functions of each of the SK domains in hPg binding and activation. Collectively, these studies generated a complex mixture of functional effects leading to a variety of different conclusions, but all of these studies agreed that there is some level of cooperation between the domains in hPg activation.…”
Cluster 1 streptokinases (SK1) from Streptococcus pyogenes (GAS) show substantially higher human plasminogen (hPg) activation activities and tighter hPg binding affinities than cluster 2b streptokinases (SK2b) in solution. The extent to which the different domains of SK are responsible for these differences is unknown. We exchanged each of the three known SK domains (α, β, and γ) between SK1 and SK2b and assessed the function of the resulting variants. Our results show that primary structural differences in the β-domains dictate these functional differences. This first report on the primary structure–functional relationship between naturally occurring SK1 and SK2b sheds new light on the mechanism of hPg activation by SK, a critical virulence determinant in this species of human pathogenic bacteria.
“…Remarkably, none of these sites have been shown to confer any substantial enzyme–substrate affinity, but (as their mutations show) these are nevertheless important in generating high catalytic rates for plasminogen activation by the SK·HPG complex. In contrast, the 250 loop in the β domain had earlier been shown to selectively enhance the affinity of the SK·HPG activator complex with substrate HPG through kringle mediated interactions. , Also, charged residues in the so-called coiled-coil region of the gamma domain are known to be involved in substrate HPG activation; , however, the exact mechanism whereby this region is important catalytically in substrate catalysis (namely, enhancing substrate turnover without conferring substrate affinity per se) has been elucidated only recently . Even though the above-mentioned studies do provide an identity to the sites whereby substrate HPG interacts with the SK·HPG complex, whether the sites act independently or in concert remains an important mechanistic question demanding a resolution.…”
To examine the global function of the key surface-exposed loops of streptokinase, bearing substrate-specific exosites, namely, the 88-97 loop in the α domain, the 170 loop in the β domain, and the coiled-coil region (Leu321-Asn338) in the γ domain, mutagenic as well as peptide inhibition studies were carried out. Peptides corresponded to the primary structure of an exosite, either individual or stoichiometric mixtures of various disulfide-constrained synthetic peptide(s) inhibited plasminogen activation by streptokinase. Remarkably, pronounced inhibition of substrate plasminogen activation by the preformed streptokinase-plasmin activator complex was observed when complementary mixtures of different peptides were used compared to the same overall concentrations of individual peptides, suggesting co-operative interactions between the exosites. This observation was confirmed with streptokinase variants mutated at one, two, or three sites simultaneously. The single/double/triple exosite mutants of streptokinase showed a nonadditive, synergistic decline in kcat for substrate plasminogen activation in the order single > double > triple exosite mutant. Under the same conditions, zymogen activation by the various mutants remained essentially native- like in terms of nonproteolytic activation of partner plasminogen. Multisite mutants also retain affinity to form 1:1 stoichiometric activator complexes with plasmin when probed through sensitive equilibrium fluorescence studies. Thus, the present results strongly support a model of streptokinase action, wherein catalysis by the streptokinase-plasmin complex operates through a distributed network of substrate-interacting exosites resident across all three domains of the cofactor protein.
“…The domain β (residues 151–287) is responsible for high-affinity binding during the activation of the plasminogen “partner” [197,[204], [205], [206]] but it also facilitates the plasminogen “substrate” binding and processing [[207], [208], [209], [210], [211]]. Finally, the domain γ (residues 288–414) is involved in stabilizing the streptokinase-plasminogen complex and in inducing its proteolytic activity [193,197,201,204,208,[212], [213], [214]]. Although having one or two major functions, each domain participates in all the steps of plasminogen activation due to the high level of cooperativity [206,215,216].…”
Section: Streptokinasementioning
confidence: 99%
“…Finally, the Arg561-Val562 peptide bond of the “substrate” molecule is hydrolytically cleaved by the “partner’s” catalytic triad His603, Asp646, and Ser741, and the final molecule of active plasmin is formed and released [201,217,219]. Regions 88–97, 164–186, and 314–342 of streptokinase were reported to be important for the plasminogen substrate processing during this final step of activation [208,209,213,215,224]. When traces of plasmin molecules are generated, streptokinase tends to form the streptokinase-plasmin complex preferentially due to the approximately three orders of magnitude higher affinity towards plasmin compared to plasminogen.…”
Myocardial infarction and ischemic stroke are the most frequent causes of death or disability worldwide. Due to their ability to dissolve blood clots, the thrombolytics are frequently used for their treatment. Improving the effectiveness of thrombolytics for clinical uses is of great interest. The knowledge of the multiple roles of the endogenous thrombolytics and the fibrinolytic system grows continuously. The effects of thrombolytics on the alteration of the nervous system and the regulation of the cell migration offer promising novel uses for treating neurodegenerative disorders or targeting cancer metastasis. However, secondary activities of thrombolytics may lead to life-threatening side-effects such as intracranial bleeding and neurotoxicity. Here we provide a structural biology perspective on various thrombolytic enzymes and their key properties: (i) effectiveness of clot lysis, (ii) affinity and specificity towards fibrin, (iii) biological half-life, (iv) mechanisms of activation/inhibition, and (v) risks of side effects. This information needs to be carefully considered while establishing protein engineering strategies aiming at the development of novel thrombolytics. Current trends and perspectives are discussed, including the screening for novel enzymes and small molecules, the enhancement of fibrin specificity by protein engineering, the suppression of interactions with native receptors, liposomal encapsulation and targeted release, the application of adjuvants, and the development of improved production systems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.